H2S Donors in creation of innovative drugs
DOI:
https://doi.org/10.24959/ophcj.17.918Keywords:
H2S, metabolism, biological effects of H2S, sulfur-containing groups, H2S-donorsAbstract
Fundamental studies have identified a new group of gaseous signaling molecules – the so-called gasotransmitters – NO, CO, and H2S, which are involved in the regulation of a large number of metabolic processes. The results of these studies allowed determining a new direction in medicinal/pharmaceutical chemistry – creation of hydrogen sulfide donor compounds as potential drugs. The article presents the main achievements in the search for new H2S donors: the main stages of H2S metabolism and its biological effects; the classes of compounds that can release hydrogen sulfide based on the nature of sulfur-containing functional groups as well as the mechanism of H2S releasing. Additionally, the characteristic of the most successful direction – creation of the so-called hybrid molecules is given. The latter are compounds bearing fragments of the well known drugs covalently bounded with groups being capable to release H2S.Downloads
References
- Lowicka, E. Hydrogen sulfide (H(2)S) – the third gas of interest for pharmacologists / E. Lowicka, J. Beltowski // Pharmacol. Reports. – 2007. – Vol. 59, Issue 1. – P. 4–24. Available at : http://if pan.krakow.pl/pjp/pdf/2007/1_4.pdf
- Li, L. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation – a tale of three gases! / L. Li, A. Hsu, P. K. Moore // Pharmacol. & Therapeutics. – 2009. – Vol. 123, Issue 3. – P. 386–400. doi: 10.1016/j.pharmthera.2009.05.005
- Pryor, W. A. Free radical biology and medicine : it’s a gas, man! / W. A. Pryor // AJP : Regulatory, Integrative and Comparative Physiol. – 2006. – Vol. 291, Issue 3. – P. R491–R511. doi: 10.1152/ajpregu.00614.2005
- Abe, K. The possible role of hydrogen sulfide as an endogenous neuromodulator / K. Abe, H. J. Kimura // Neurosci. – 1996. – Vol. 16, Issue 3. – P. 1066–1071. Available at : http://www.jneurosci.org/content/jneuro/16/3/1066.full.pdf
- Brosnan, J. T.The sulfur–containing amino acids : an overview / J. T. Brosnan, M. E. Brosnan // J. Nutrit. – 2006. – Vol. 136, Issue 6. – P. 1636–1640. Available at : http://jn.nutrition.org/content/136/6/1636S.full.pdf+html
- Impaired homocysteine metabolism and atherothrombotic disease / P. Durand, M. Prost, N. Loreau et al. // D. Lab. Invest. – 2001. – Vol. 81, Issue 5. – P. 645–672. Available at : http://www.nature.com/labinvest/journal/v81/n5/pdf/3780275a.pdf
- Hayes, K. C. Taurine in metabolism / K. C. Hayer, J. A. Sturman // Ann. Rev. Nutr. – 1981. – Vol. 1. – P. 401–425.
- Kabil, O. Enzymology of H2S Biogenesis, Decay and Signaling / O. Kabil, R. Banerjee // Antiox. Redox. Signal. – 2014. – Vol. 20, Issue 5. – P. 770–782. doi: 10.1089/ars.2013.5339
- Kimura, H. Hydrogen sulfide : its production and functions / H. Kimura // Exp. Physiol. – 2011. – Vol. 96, Issue 9. – P. 833–835. doi: 10.1113/expphysiol.2011.057455
- Kimura, H. Physiological role of hydrogen sulfide and polysulfide in the central nervous system / H. Kimura // Neurochem. Int. – 2013. – Vol. 63,
- Issue 5. – P.492–497. doi: 10.1016/j.neuint.2013.09.003
- Dynamic Change of Hydrogen Sulfide After Traumatic Brain Injury and its Effect in Mice / M. Zhang, H. Shan, T. Wang et al. // Neurochem. Res. – 2013. – Vol. 38, Issue 4. – P.714–725.doi: 10.1007/s11064–013–0969–4
- Vascular Endothelium Expresses 3–Mercaptopyruvate Sulfurtransferase and Produces Hydrogen Sulfide / N. Shibuya, Y. Mikami, Y. Kimura et al. // J. Biochem. – 2009. – 146, Issue 5. – P. 623–626. doi: 10.1093/jb/mvp111
- Wang, R. Physiological Implications of Hydrogen Sulfide : A Whiff Exploration That Blossomed / R. Wang // Physiol. Rev. – 2012. – Vol. 92, Issue 2. – P.791–896. doi: 10.1152/physrev.00017.2011
- A novel pathway for the production of hydrogen sulfide from D–cysteine in mammalian cells / N. Shibuya, S. Koike, M. Tanaka et al. // Nature Commun. – 2013. – Vol. 4. – 1366 p. doi: 10.1038/ncomms2371
- Jakubowski, H. Synthesis of homocysteine thiolactone by methionyl–tRNA synthetase in cultured mammalian cells / H. Jakubowski, E. Goldman // FEBS Lett. – 1993. – Vol. 317, Issue 3. – P. 237–240. doi: 10.1016/0014–5793(93)81283–6
- Eto, K. The production of hydrogen sulfide is regulated by testosterone and S–adenosyl–l–methionine in mouse brain / K. Eto, H. Kimura // J. Neurochem. –2002. – Vol. 83, Issue 1. – P.80–86. doi: 10.1046/j.1471–4159.2002.01097.x
- Obeid, R. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia / R. Obeid, W. Herrmann // FEBS Lett. – 2006. – Vol. 580, Issue 13. – P. 2994–3005. doi: 10.1016/j.febslet.2006.04.088
- Kimura, H. Hydrogen Sulfide Is a Signaling Molecule and a Cytoprotectant / H. Kimura, Y. Kimura, N. Shibuya // Antioxid. Redox. Signal. – 2012. – Vol. 17, Issue 1. – P.45–57. doi: 10.1089/ars.2011.4345
- Thioredoxin and dihydrolipoic acid are required for 3–mercaptopyruvate sulfurtransferase to produce hydrogen sulfide / Y. Mikami, N. Shibuya, Y. Kimura et al. // Biochem. J. – 2011. – Vol. 439, Issue 3. – P. 479–485. doi: 10.1042/BJ20110841
- Qian, L. Chemical foundations of hydrogen sulfide biology / L. Qian, J. R. Lancaster // Nitric Oxide. – 2013. – Vol. 35. – P. 21–34. doi: 10.1016/j. niox.2013.07.001
- Zhao, Y. Hydrogen sulfide (H2S) releasing agents : chemistry and biological applications / Y. Zhao, T. D. Biggs, M. Xian // Chem. Comm. – 2014. – Vol. 50, Issue 8. – P. 11788–11805. doi: 10.1039/C4CC00968A
- Natural Products Containing Hydrogen Sulfide Releasing Moieties / M. D. Pluth, T. S. Bailey, M. D. Hammers et al. // Synlett. – 2015. – Vol. 26, Issue 19. – P. 2633–2643. doi: 10.1055/s–0035–1560638
- Polysulfides are possible H2S–derived signaling molecules in rat brain / Y. Kimura, Y. Mikami, K. Osumi et al. // FASEB J. – 2013. – Vol. 27, Issue 6. – P. 2451–2457. doi: 10.1096/fj.12–226415
- Kimura, H. Hydrogen sulfide : its production, release and functions / H. Kimura // Amino Acids. – 2011. – Vol. 41, Issue 1. – P. 113–121. doi: 10.1007/s00726–010–0510–x
- Hughes, M. N. Making and working with hydrogen sulfide / M. N. Hughes, M. N. Centelles, K. P. Moore // Free Radic. Biol. Med. – 2009. – Vol. 47, Issue 10. – P. 1346–1353. doi: 10.1016/j.freeradbiomed.2009.09.018
- Guo, W. Hydrogen sulfide and translational medicine / W. Guo, Z. Y. Cheng, Y. Z. Zhu // Acta Pharmacol. Sinica. – 2013. – Vol. 34, Issue 10. – P. 1284–1291. doi: 10.1038/aps.2013.127
- Kashfi, K. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide–releasing chimeras / K. Kashfi, K. R. Olson // Biochem. Pharmacol. 2013. – Vol. 85, Issue 5. – P. 689–703. doi: 10.1016/j.bcp.2012.10.019
- Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest / M. Carballal, E. Trujillo, S. Cuevasanta et al. // Free Rad. Biol. Med. – 2011. – Vol. 50, Issue 1, P. 196–205. doi: 10.1016/j.freeradbiomed.2010.10.705
- Zhao, Y. Cysteine–Activated Hydrogen Sulfide (H2S) Donors / Y. Zhao, H. Wang, M. J. Xian // Am. Chem. Soc. – 2011. – Vol. 133, Issue 1. – P. 15–17. doi: 10.1021/ja1085723
- Wang, R. Two’s company, three’s a crowd : can H2S be the third endogenous gaseous transmitter? / R. Wang // FASEB J. – 2002. – Vol. 16, Issue 13. – P. 1792–1798. doi: 10.1096/fj.02–0211hyp
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener / W. Zhao, J. Zhang, Y. Lu, R. Wang // EMBO J. – 2001. – Vol. 20, Issue 21. – P. 6008–6016. doi: 10.1093/emboj/20.21.6008
- Tang, G. Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle / G. Tang // Mol. Pharmacol. –2005. – Vol. 68. – P. 1757–1764. doi: 10.1124/mol.105.017467
- Zhao, W. H2S–induced vasorelaxation and underlying cellular and molecular mechanisms / W. Zhao, R. Wang // Am. J. Physiol. Heart Circ. Physiol. – 2002. – Vol. 283, Issue 2. – P. H474–H480. doi: 10.1152/ajpheart.00013.2002
- Hydrogen sulfide in combination with taurine or cysteic acid reversibly abolishes sodium currents in neuroblastoma cells / M. W. Warenycia, J. A. Steele, E. Karpinski, R. J. Reiffenstein // Neurotox. – 1989. – Vol. 10. – P. 191–199.
- Biomarkers of oxidative and nitro–oxidative stress: conventional and novel approaches / A. Cipak Gasparovic, N. Zarkovic, K. Zarkovic et al. // Brit. J. Pharmacol. – 2017. doi: 10.1111/bph.13673
- Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells / J. J. Lim, Y.–H. Liu et al. // Am. J. Physiol. Cell Physiol. – 2008. – Vol. 295, Issue 5. – P. C1261–C1270. doi: 10.1152/ajpcell.00195.2008
- Hydrogen Sulfide–Induced Dual Vascular Effect Involves Arachidonic Acid Cascade in Rat Mesenteric Arterial Bed / R. d’E. Di Villa Bianca, R. Sorrentino, C. Coletta et al. // J. Pharmacol. Exp. Ther. – 2011. –Vol. 337, Issue 1. – P. 59–64. doi: 10.1124/jpet.110.176016
- The Role of Endogenous H2S in Cardiovascular Physiology / N. Skovgaard, A. Gouliaev, M. Aalling, U. Simonsen // Curr. Pharm. Biotechnol. – 2011. – Vol. 12, Issue 9. – P. 1385–1393. doi: 10.2174/138920111798280956
- Contractile and Vasorelaxant Effects of Hydrogen Sulfide and Its Biosynthesis in the Human Internal Mammary Artery / G. D. Webb, L. H. Lim, V. M. S. Oh et al. // J. Pharmacol. Exp. Ther. – 2008. – Vol. 324, Issue 2. – P. 876–882. doi: 10.1124/jpet.107.133538
- Lavu, M. Hydrogen sulfide–mediated cardioprotection : mechanisms and therapeutic potential / M. Lavu, S. Bhushan, D. J. Lefler // Clin. Sci. – 2011. – Vol. 120, Issue 6. – P. 219–229. doi: 10.1042/CS20100462
- Brittain, T. The interaction of human neuroglobin with hydrogen sulphide / T. Brittain, Y. Yosaatmadja, K. Henty // IUBMB Life. – 2008. – Vol. 60, Issue 2. – P. 135–138.doi: 10.1002/iub.16
- Hydrogen sulfide mitigates matrix metalloproteinase–9 activity and neurovascular permeability in hyperhomocysteinemic mice / N. Tyagi, S. Givvimani, N. Qipshidze et al. // Neurochem. Int. – 2010. – Vol. 56, Issue 2. – P. 301–307. doi: 10.1016/j.neuint.2009.11.002
- Calvert, J. W. Novel Insights Into Hydrogen Sulfide–Mediated Cytoprotection / J. W. Calvert, W. A. Coetzee, D. J. Lefer //Antioxid. Redox. Signal. – 2010. – Vol. 12, Issue 10. – P. 1203–1217. doi: 10.1089/ars.2009.2882
- Physiological and pharmacological features of the novel gasotransmitter : Hydrogen sulfide / D. Mancardi, C. Penna, A. Merlino et al. // Biochim. Biophys. Acta. – 2009. – Vol. 1787, Issue 7. – P. 864–872. doi: 10.1016/j.bbabio.2009.03.005
- Whiteman, M. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? / M. Whiteman, P. K. Moore // J. Cell Mol. Med. – 2009. – Vol. 13, Issue 3. – P. 488–507. doi: 10.1111/j.1582–4934.2009.00645.x
- Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems / V. S. Lin, W. Chen, M. Xian, C. J. Chang // Chemical. Soc. Rev. – 2015. – Vol. 44, Issue 14. – P. 4596–4618. doi: 10.1039/C4CS00298A
- Юрченко, П. О. Роль системи гідроген сульфіду в механізмах ураження мозку за умов гіпергомоцистеїнемії : дис. … н. ст. канд. мед. наук : 14.01.32 / П. О. Юрченко. – Вінниця, 2016.
- Пентюк, Н. О. Гіперпродукція вазоактивних медіаторів як патогенетичний чинник розвитку ускладнень цирозу печінки у щурів / Н. О. Пентюк, Н. В. Харченко // Сучасна гастроентерол. – 2010. – № 2 (52), С. 33–43. Режим доступу : http://vitapol.com.ua/user_files/pdfs/gastro/978639636524872_06062010115352.pdf
- Li, L. Could hydrogen sulfide be the next blockbuster treatment for inflammatory disease? / L. Li, P. K. Moore // Expert. Rev. Clin. Pharmacol. – 2013. – Vol. 6, Issue 6. – P. 593–595. doi: 10.1586/17512433.2013.842126
- Wallace, J. L. Hydrogen sulfide–releasing anti–inflammatory drugs / J. L. Wallace // Trends Pharmacol. Sci. – 2007. – Vol. 28, Issue 10. – P. 501–505. doi: 10.1016/j.tips.2007.09.003
- Hydrogen sulfide induces ICAM–1 expression and neutrophil adhesion to caerulein–treated pancreatic acinar cells through NF–κB and Src–family kinases pathway / R. Tamizhselvi, Y. H. Koh, J. Sun et al. // Exp. Cell Res. – 2010. – Vol. 316, Issue 9. – P. 1625–1636. doi: 10.1016/j.yexcr.2010.02.044
- Pro–inflammatory effects of hydrogen sulphide on substance P in caerulein–induced acute pancreatitis / M. Bhatia, J. N. Sidhapuriwala et al. // J. Cell Mol. Med. – 2008. – Vol. 12, Issue 2. – P. 580–590. doi: 10.1111/j.1582–4934.2007.00131.x
- Hydrogen sulfide donors in research and drug development / Z. J. Song, M. Y. Ng, Z. W. Lee et al. // Med. Chem. Comm. – 2014. – Vol. 5, Issue 5. – 557 p. doi: 10.1039/C3MD00362K
- Forgan, L. G. Oxygen consumption, ventilation frequency and cytochrome c oxidase activity in blue cod (Parapercis colias) exposed to hydrogen sulphide or isoeugenol / L. G. Forgan, M. E. Forster // Comp. Biochem. Physiol. Toxicol. Pharmacol : CBP. – 2010. – Vol. 151, Issue 1. – P. 57–65. doi: 10.1016/j.cbpc.2009.08.008
- Baumgart, K. Applying gases for microcirculatory and cellular oxygenation in sepsis : effects of nitric oxide, carbon monoxide, and hydrogen sulfide / K. Baumgart, P. Radermacher, F. Wagner // Curr. Opin. Anaesthesiol. – 2009. – Vol. 22, Issue 2. – P. 168–176. doi: 10.1097/ACO.0b013e328328d22f
- H2S during circulatory shock : Some unresolved questions / O. McCook, P. Radermacher, C. Volani et al. // Nitric Oxide. – 2014. – Vol. 41, P. 48–61. doi: 10.1016/j.niox.2014.03.163
- Hartle, M. D. A practical guide to working with H2S at the interface of chemistry and biology / M. D. Hartle, M. D. Pluth // Chem. Soc. Rev. – 2016. – Vol. 45, Issue 2. – P. 6108–6117. doi: 10.1039/C6CS00212A
- Wallace, J. L. Hydrogen sulfide–based therapeutics: exploiting a unique but ubiquitous gasotransmitter / J. L. Wallace, R. Wang // Nat. Rev. Drug Discov. –2015. – Vol. 14, Issue 5. – P. 329–345. doi: 10.1038/nrd4433
- Onions? A global benefit to health / G. Griffiths, L. Trueman et al. // Phytother. Res. – 2002. – Vol. 16, Issue 7. – P. 603–615. doi: 10.1002/ptr.1222
- Смаглий, Л. Сероводород – новое лекарство для сосудов / Л. Смаглий // Биомолекула. – 2013. Режим доступа : http://biomolecula.ru/content/1373.
- Synthesis and Biological Effects of Hydrogen Sulfide (H2S) : Development of H2S–Releasing Drugs as Pharmaceuticals / G. Caliendo, G. Cirino, V. Santagada, J. L. Wallace // J. Med. Chem. – 2010. – Vol. 53, Issue 17. – P. 6275–6286. doi: 10.1021/jm901638j
- Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors / M. Whiteman, A. Perry, Z. Zhou et al. // Handbook of Exp. Pharmacol. – 2015. – Vol. 230. – P. 337–363. doi: 10.1007/978–3–319–18144–8_17
- Characterization of a Novel, Water–Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137) : New Insights Into the Biology of Hydrogen Sulfide / L. Li, M. Whiteman, Y. Y. Guan et al. // Circulation. – 2008. – Vol. 117, Issue 18. – P. 2351–2360. doi: 10.1161/CIRCULATIONAHA.107.753467
- The Slow–Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti–Cancer Effects In Vitro and In Vivo / Z. W. Lee, J. Zhou et al. // PLoS One. – 2011. – Vol. 6, Issue 6. – e21077 p. doi: 10.1371/journal.pone.0021077
- Synthesis and evaluation of phosphorodithioate–based hydrogen sulfide donors / C. Park, Y. Zhao, Z. Zhu et al. // Mol. Bio. Syst. – 2013. – Vol. 9, Issue 10. –P. 2430–2434. doi: 10.1039/C3MB70145J
- Kodela, R. NOSH–Aspirin : A Novel Nitric Oxide–Hydrogen Sulfide–Releasing Hybrid: A New Class of Anti–inflammatory Pharmaceuticals / R. Kodela, M. Chattopadhyay, K. Khosrow // ACS Med. Chem. Lett. – 2012. – Vol. 3, Issue 3. – P. 257–262. doi: 10.1021/ml300002m
- Enhanced chemopreventive effects of a hydrogen sulfide–releasing anti–inflammatory drug (ATB–346) in experimental colorectal cancer / W. Elsheikh, R. W. Blackler, K. L. Flannigan, J. L. Wallace // Nitric Oxide. – 2014. – Vol. 41. – P.131–137. doi: 10.1016/j.niox.2014.04.006
- Thioglycine and l–thiovaline : Biologically active H2S–donors / Z. Zhou, M. von Wantoch Rekowski, C. Coletta, C. Szabo et al. // Bioorg. Med. Chem. – 2012. – Vol. 20, Issue 8. – P. 2675–2678. doi: 10.1016/j.bmc.2012.02.028
- Light–Induced Hydrogen Sulfide Release from “Caged” gem–Dithiols / N. O. Devarie–Baez, P. E. Bagdon, B. Peng et al. // Org. Lett. – 2013. – Vol. 15, Issue 11. – P. 2786–2789. doi: 10.1021/ol401118k
- New Biologically Active Hydrogen Sulfide Donors / T. Roger, F. Raynaud et al. // ChemBioChem. – 2013. – Vol. 14, Issue 17. – P. 2268–2271. doi: 10.1002/cbic.201300552
- Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages / N. Fukushima, N. Ieda et al. // Chem. Commun. – 2014. – Vol. 50, Issue 5. – P. 587–589. doi: 10.1039/C3CC47421F
- Anti–inflammatory and gastrointestinal effects of a novel diclofenac derivative / L. Li, G. Rossoni et al. // Free Rad. Biol. Med. – 2007. – Vol. 42, Issue 5. – P. 706–719. doi: 10.1016/j.freeradbiomed.2006.12.011
- Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose–Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells / Q. Huang, A. Sparatore, P. Del Soldato et al. // PloS ONE. – 2014. – Vol. 9, Issue 6. – e97315 p. doi: 10.1371/journal.pone.0097315
- NOSH–aspirin (NBS–1120), a novel nitric oxide– and hydrogen sulfide–releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model / M. Chattopadhyay, R. Kodela, K. R., Olson, K. Kashfi // Biochem. Biophys. Res. Commun. – 2012. – Vol. 419, Issue 3. – P. 523–528. doi: 10.1016/j.bbrc.2012.02.051
- Elsey, D. J. Regulation of cardiovascular cell function by hydrogen sulfide (H2S) / D. J. Elsey, R. C. Fowkes, G. F. Baxter // Cell Biochem. Func. – 2010. – Vol. 28, Issue 2. – P. 95–106. doi: 10.1002/cbf.1618
- Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral–administered homocysteine in mice / P. K. Kamat, A. Kalani, S. Givvimani et al. // Neurosci. – 2013. – Vol. 252. – P. 302–319. doi: 10.1016/j.neuroscience.2013.07.051
- Aruoma, O. I. Protection Against Oxidative Damage and Cell Death by the Natural Antioxidant Ergothioneine / O. I. Aruoma, J. P. E. Spencer, N. Mahmood // Food Chem. Toxicol. – 1999. – Vol. 37, Issue 11. – P. 1043–1053. doi: 10.1016/S0278–6915(99)00098–8
- Mitsuyama, H. Uptake and antioxidant effects of ergothioneine in human erythrocytes / H. Mitsuyama, J. M. May // Clin. Sci. – 1999. – Vol. 97, Issue 4. – P. 407–411. doi: 10.1042/cs0970407
- Lesyk, R. B. 4–Thiazolidones : Centenarian History, Current Status and Perspectives for Modern Organic and Medicinal Chemistry / R. B. Lesyk, B. S. Zimenkovsky // Curr. Org. Chem. – 2004. – Vol. 8, Issue 16. – P. 1547–1577. doi: 10.2174/1385272043369773
- Пат. України на корисну модель G 09 B 23/28. Спосіб зниження ульцерогенної дії нестероїдних протизапальних препаратів на експериментальних моделях у щурів / Ільків, І. І., Лесик, Р. Б., Скляров, О. Я. – 108412 ; опубл. 11.07.2016, Бюл. № 13.
- Ilkiv, I. Evaluation of novel 4–thiazolidinone–based derivatives as possible cytoprotective agents against stress model in rats / I. Ilkiv, R. Lesyk, O. J. Sklyarov // Appl. Pharm. Sci. – 2017. – Vol. 7, Issue 01. – P. 199–203. doi: 10.7324/JAPS.2017.70129
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).